Roozen, Geert V. T.; van Schuijlenburg, Roos; Hensen, Annefleur D. O.; Koopman, Jan Pieter R.; Lamers, Olivia A. C.; Geurten, Fiona J. A.; Sijtsma, Jeroen C.; Baalbergen, Els; Janse, Jacqueline J.; Chevalley-Maurel, Severine; Naar, Chanel M.; Bezemer, Sascha; Kroeze, Hans; van de Stadt, Huybert J. F.; de Visser, Bram; Meij, Pauline; Tihaya, Mara S.; Colstrup, Emil; Iliopoulou, Eva; de Bes-Roeleveld, Helena M.; Wessels, Els; van der Stoep, M. Y. Eileen C.; Janse, Chris J.; Murugan, Rajagopal; Franke-Fayard, Blandine M. D.

Validating human induced pluripotent stem cell-specific fi c quality control tests for the release of an intermediate drug product in a Good Manufacturing Practice quality system

CYTOTHERAPY

IF3.2

2024-09-012

OAAI

Good Manufacturing Practice-compliant human induced pluripotent stem cells: from bench to putative clinical products

CYTOTHERAPY

IF3.2

2024-06-016

OAAI

EMA commentary on the guideline on quality, nonclinical and clinical aspects of medicinal products containing genetically modified cells

BRITISH JOURNAL OF CLINICAL PHARMACOLOGY

IF3

2024-04-020

PRE

Timed adoptive T cell transfer during chemotherapy in patients with recurrent platinum-sensitive epithelial ovarian cancer

JOURNAL FOR IMMUNOTHERAPY OF CANCER

IF10.6

2023-11-107

OAAI

Safety and infectivity of female cercariae in Schistosoma- naïve, healthy participants: a controlled human Schistosoma mansoni infection study

未患血吸虫的健康参与者中女性尾蚴的安全性和感染性: 一项对照人类曼氏血吸虫感染研究

EBIOMEDICINE

IF10.8

2023-11-015

OAAI

Koopman, Jan Pieter R.; Houlder, Emma L.; Janse, Jacqueline J.; Casacuberta-Partal, Miriam; Lamers, Olivia A. C.; Sijtsma, Jeroen C.; de Dood, Claudia; Hilt, Stan T.; Ozir-Fazalalikhan, Arifa; Kuiper, Vincent P.; Roozen, Geert V. T.; de Bes-Roeleveld, Laura M.; Kruize, Yvonne C. M.; Wammes, Linda J.; Smits, Hermelijn H.; van Lieshout, Lisette; van Dam, Govert J.; van Amerongen-Westra, Inge M.; Meij, Pauline; Corstjens, Paul L. A. M.; Jochems, Simon P.; van Diepen, Angela; Yazdanbakhsh, Maria; Hokke, Cornelis H.; Roestenberg, Meta

Causal chemoprophylactic activity of cabamiquine against Plasmodium falciparum in a controlled human malaria infection: a randomised, double-blind, placebo-controlled study in the Netherlands

LANCET INFECTIOUS DISEASES

IF31

2023-10-019

OAAI

van der Plas, Johan L.; Kuiper, Vincent P.; Bagchus, Wilhelmina M.; Boedding, Matthias; Yalkinoglu, Ozkan; Tappert, Aliona; Seitzinger, Andrea; Spangenberg, Thomas; Bezuidenhout, Deon; Wilkins, Justin; Oeuvray, Claude; Dhingra, Satish K.; Thathy, Vandana; Fidock, David A.; Smidt, Lisanne C. A.; Roozen, Geert V. T.; Koopman, Jan Pieter R.; Lamers, Olivia A. C.; Sijtsma, Jeroen; van Schuijlenburg, Roos; Wessels, Els; Meij, Pauline; Kamerling, Ingrid M. C.; Roestenberg, Meta; Khandelwal, Akash

Adoptive T-cell therapy during chemotherapy with or without peginterferon-α (IFNα) in patients with platinum sensitive recurrent epithelial ovarian cancer (EOC)

ANNALS OF ONCOLOGY

IF65.4

2021-09-012

OAAI

Advanced therapy medicinal product manufacturing under the hospital exemption and other exemption pathways in seven European Union countries

CYTOTHERAPY

IF3.2

2020-10-0122

OAAI

HA-1H T-Cell Receptor Gene Transfer to Redirect Virus-Specific T Cells for Treatment of Hematological Malignancies After Allogeneic Stem Cell Transplantation: A Phase 1 Clinical Study

FRONTIERS IN IMMUNOLOGY

IF5.9

2020-08-2030

OAAI

A Randomized Controlled Trial to Investigate Safety and Variability of Egg Excretion After Repeated Controlled Human Hookworm Infection

JOURNAL OF INFECTIOUS DISEASES

IF4.5

2020-07-1012

OAAI

What does cell therapy manufacturing cost? A framework and methodology to facilitate academic and other small-scale cell therapy manufacturing costings

细胞疗法的制造成本是多少？促进学术和其他小规模细胞疗法制造成本的框架和方法

CYTOTHERAPY

IF3.2

2020-07-0145

OAAI

Preclinical Development of Autologous Hematopoietic Stem Cell-Based Gene Therapy for Immune Deficiencies: A Journey from Mouse Cage to Bed Side

PHARMACEUTICS

IF5.5

2020-06-135

OAAI

A double-blind, placebo-controlled phase 1/2a trial of the genetically attenuated malaria vaccine PfSPZ-GA1

SCIENCE TRANSLATIONAL MEDICINE

IF14.6

2020-05-2054

PREAI

Roestenberg, Meta; Walk, Jona; van der Boor, Saskia C.; Langenberg, Marijke C. C.; Hoogerwerf, Marie-Astrid; Janse, Jacqueline J.; Manurung, Mikhael; Yap, X. Zen; Garcia, Amanda Fabra; Koopman, Jan Pieter R.; Meij, Pauline; Wessels, Els; Teelen, Karina; van Waardenburg, Youri M.; van de Vegte-Bolmer, Marga; van Gemert, Geert Jan; Visser, Leo G.; van der Ven, Andre J. A. M.; de Mast, Quirijn; Natasha, K. C.; Abebe, Yonas; Murshedkar, Tooba; Billingsley, Peter F.; Richie, Tom L.; Sim, B. Kim Lee; Janse, Chris J.; Hoffman, Stephen L.; Khan, Shahid M.; Sauerwein, Robert W.

A controlled human Schistosoma mansoni infection model to advance novel drugs, vaccines and diagnostics

NATURE MEDICINE

IF50

2020-02-1776

OAAI

Langenberg, Marijke C. C.; Hoogerwerf, Marie-Astrid; Koopman, Jan Pieter R.; Janse, Jacqueline J.; Kos-van Oosterhoud, Janneke; Feijt, Carola; Jochems, Simon P.; de Dood, Claudia J.; van Schuijlenburg, Roos; Ozir-Fazalalikhan, Arifa; Manurung, Mikhael D.; Sartono, Erliyani; van der Beek, Martha T.; Winkel, Beatrice M. F.; Verbeek-Menken, Petra H.; Stam, Koen A.; van Leeuwen, Fijs W. B.; Meij, Pauline; van Diepen, Angela; van Lieshout, Lisette; van Dam, Govert J.; Corstjens, Paul L. A. M.; Hokke, Cornelis H.; Yazdanbakhsh, Maria; Visser, Leo G.; Roestenberg, Meta

Pauline Meij

个人简介

教育背景

工作经历

荣誉奖项

研究方向